More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]

SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]

GTX635679
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:5000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:500-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    HL344
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Castro V, Pérez-Berna AJ, Calvo G, et al. Three-Dimensional Remodeling of SARS-CoV2-Infected Cells Revealed by Cryogenic Soft X-ray Tomography. ACS Nano. 2023,17(22):22708-22721. doi: 10.1021/acsnano.3c07265
    Read this paper
  • Uemura K, Nobori H, Sato A, et al. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses. Proc Natl Acad Sci U S A. 2023,120(42):e2304139120. doi: 10.1073/pnas.2304139120
    Read this paper
  • Imbiakha B, Ezzatpour S, Buchholz DW, et al. Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5. Sci Adv. 2023,9(38):eadj1736. doi: 10.1126/sciadv.adj1736
    Read this paper
  • Pérez-Vargas J, Worrall LJ, Olmstead AD, et al. A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants. Emerg Microbes Infect. 2023,12(2):2246594. doi: 10.1080/22221751.2023.2246594
    Read this paper
  • Andreu S, von Kobbe C, Delgado P, et al. Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo. Front Microbiol. 2023,14:1185504. doi: 10.3389/fmicb.2023.1185504
    Read this paper
  • Cloherty APM, Rader AG, Patel KS, et al. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade. Emerg Microbes Infect. 2023,12(1):2195020. doi: 10.1080/22221751.2023.2195020
    Read this paper
  • Li Z, Hao P, Zhao Z, et al. The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation. Signal Transduct Target Ther. 2023,8(1):53. doi: 10.1038/s41392-023-01335-5
    Read this paper
  • Gonçalves R, Couto J, Ferreirinha P, et al. SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice. iScience. 2023,26(2):105972. doi: 10.1016/j.isci.2023.105972
    Read this paper
  • Yamamoto Y, Nakano Y, Murae M, et al. Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid. Int J Mol Sci. 2022,24(1). doi: 10.3390/ijms24010020
    Read this paper
  • Yamamoto Y, Inoue T, Inoue M, et al. SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. Int J Mol Sci. 2022,23(24). doi: 10.3390/ijms232415834
    Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions